Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic

Overview

Journal Thromb Haemost

Publisher Thieme

Specialties Cardiology & Vascular Diseases
Hematology

Date 2021 Jul 31

PMID 34331297

Citations 9

Authors

Toshiaki Iba

Jerrold H Levy

Marcel Levi

Affiliations

Soon will be listed here.

Abstract

Several viral infectious diseases have emerged or re-emerged from wildlife vectors that have generated serious threats to global health. Increased international travel and commerce increase the risk of transmission of viral or other infectious diseases. In addition, recent climate changes accelerate the potential spread of domestic disease. The coronavirus disease 2019 (COVID-19) pandemic is an important example of the worldwide spread, and the current epidemic will unlikely be the last. Viral hemorrhagic fevers, such as dengue and Lassa fevers, may also have the potential to spread worldwide with a significant impact on public health with unpredictable timing. Based on the important lessons learned from COVID-19, it would be prudent to prepare for future pandemics of life-threatening viral diseases. The key concept that connect COVID-19 and viral hemorrhagic fever is the coagulation disorder. This review focuses on the coagulopathy of acute viral infections since hypercoagulability has been a major challenge in COVID-19, but represents a different presentation compared with viral hemorrhagic fever. However, both thrombosis and hemorrhage are understood as the result of thromboinflammation due to viral infections, and the role of anticoagulation is important to consider.

Citing Articles

Macrophage fate: to kill or not to kill?.

Marrufo A, Flores-Mireles A Infect Immun. 2024; 92(9):e0047623.

PMID: 38829045 PMC: 11385966. DOI: 10.1128/iai.00476-23.

Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases.

Kaur H, Bawaskar R, Khobragade A, Kalra D, Packiam V, Khan M PLoS One. 2023; 18(11):e0292783.

PMID: 37967089 PMC: 10650991. DOI: 10.1371/journal.pone.0292783.

Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19.

Cosmi B, Giannella M, Fornaro G, Cristini F, Patacca A, Castagna A BMC Infect Dis. 2023; 23(1):718.

PMID: 37875792 PMC: 10594805. DOI: 10.1186/s12879-023-08297-7.

Severe Gastrointestinal Hemorrhage due to Monkeypox Virus-Associated Proctocolitis.

Taj S, Austin C, Hussain A, Babar M, Sanekommu H, Imburgio S Case Rep Gastrointest Med. 2023; 2023:9981631.

PMID: 37492076 PMC: 10365909. DOI: 10.1155/2023/9981631.

Development and validation of an artificial intelligence model for the early classification of the aetiology of meningitis and encephalitis: a retrospective observational study.

Choi B, Choi Y, Sung M, Ha W, Chu M, Kim W EClinicalMedicine. 2023; 61:102051.

PMID: 37415843 PMC: 10319989. DOI: 10.1016/j.eclinm.2023.102051.

References

Kilickap S, Abali H, Celik I . Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol. 2003; 21(18):3542; author reply 3543. DOI: 10.1200/JCO.2003.99.046. View

Peters C, Khan A . Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis. 2002; 34(9):1224-31. DOI: 10.1086/339864. View

Patell R, Chiasakul T, Bauer E, Zwicker J . Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis. Thromb Haemost. 2020; 121(1):76-85. PMC: 7869062. DOI: 10.1055/s-0040-1721664. View

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Ryabchikova E, Kolesnikova L, Luchko S . An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis. 1999; 179 Suppl 1:S199-202. DOI: 10.1086/514293. View

Pang X, Zhang R, Cheng G . Progress towards understanding the pathogenesis of dengue hemorrhagic fever. Virol Sin. 2016; 32(1):16-22. PMC: 6702245. DOI: 10.1007/s12250-016-3855-9. View

Malavige G, Ogg G . Pathogenesis of vascular leak in dengue virus infection. Immunology. 2017; 151(3):261-269. PMC: 5461104. DOI: 10.1111/imm.12748. View

Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon D, Van Tassell B . Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021; 21(5):319-329. PMC: 8023349. DOI: 10.1038/s41577-021-00536-9. View

Ahmed S, Zimba O, Gasparyan A . COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021; 40(7):2611-2619. PMC: 7968918. DOI: 10.1007/s10067-021-05691-x. View

10.

Lednicky J . Hantaviruses. a short review. Arch Pathol Lab Med. 2003; 127(1):30-5. DOI: 10.5858/2003-127-30-. View

11.

Perez-Toledo M, Beristain-Covarrubias N . A new player in the game: platelet-derived extracellular vesicles in dengue hemorrhagic fever. Platelets. 2020; 31(4):412-414. DOI: 10.1080/09537104.2020.1755031. View

12.

Foley J, Conway E . Cross Talk Pathways Between Coagulation and Inflammation. Circ Res. 2016; 118(9):1392-408. DOI: 10.1161/CIRCRESAHA.116.306853. View

13.

Middleton E, He X, Denorme F, Campbell R, Ng D, Salvatore S . Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020; 136(10):1169-1179. PMC: 7472714. DOI: 10.1182/blood.2020007008. View

14.

Kularatne S . Dengue fever. BMJ. 2015; 351:h4661. DOI: 10.1136/bmj.h4661. View

15.

Schindell B, Webb A, Kindrachuk J . Persistence and Sexual Transmission of Filoviruses. Viruses. 2018; 10(12). PMC: 6316729. DOI: 10.3390/v10120683. View

16.

Cipitelli M, Paiva I, Badolato-Correa J, de-Oliveira-Pinto L . Influence of chemokines on the endothelial permeability and cellular transmigration during dengue. Immunol Lett. 2019; 212:88-97. DOI: 10.1016/j.imlet.2019.06.001. View

17.

Kox M, Waalders N, Kooistra E, Gerretsen J, Pickkers P . Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions. JAMA. 2020; . PMC: 7489366. DOI: 10.1001/jama.2020.17052. View

18.

Nazy I, Jevtic S, Moore J, Huynh A, Smith J, Kelton J . Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thromb Haemost. 2021; 19(5):1342-1347. PMC: 8014456. DOI: 10.1111/jth.15283. View

19.

Lippi G, Plebani M, Henry B . Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020; 506:145-148. PMC: 7102663. DOI: 10.1016/j.cca.2020.03.022. View

20.

Ryan S, Carlson C, Mordecai E, Johnson L . Global expansion and redistribution of Aedes-borne virus transmission risk with climate change. PLoS Negl Trop Dis. 2019; 13(3):e0007213. PMC: 6438455. DOI: 10.1371/journal.pntd.0007213. View